MRT (TSE:6034) Marketable Securities: 円562 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6034 MRT Inc TSE:6034
60 GF Score
Price 円650.00
GF Value 円618.55
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MRT Marketable Securities?

MRT TSE:6034 +0.93% 60 Marketable Securities is 円562 Mil as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 60/100 and a GF Value™ of 円618.55 (Fairly Valued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. MRT's Marketable Securities for the quarter that ended in Mar. 2026 was 円562 Mil.

MRT's annual Marketable Securities declined from Dec. 2023 (円26 Mil) to Dec. 2024 (円16 Mil) but then increased from Dec. 2024 (円16 Mil) to Dec. 2025 (円562 Mil).

MRT  (TSE:6034) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

MRT Marketable Securities Related Terms

MRT Marketable Securities Historical Data

* Premium members only.

The historical data trend for MRT's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT Marketable Securities Chart

MRT Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.64 7.72 26.42 15.65 562.39

MRT Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.19 253.60 557.75 562.39 562.16
TSE:6034
60GF Score
MRT Inc TSE:6034
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRT Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円562 Mil mean?
MRT (TSE:6034) has a Marketable Securities of 円562 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on MRT and its competitors.
Is MRT's Marketable Securities too high?
MRT's current Marketable Securities is 円562 Mil. Overall, MRT has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Marketable Securities compare to HCA and THC?
MRT's Marketable Securities of 円562 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on MRT and its competitors. MRT's current Marketable Securities is 円562 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円618.55, compared to a current price of 円650.00 — trading 5.1% above its estimated fair value. The current Marketable Securities is 円562 Mil. MRT's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For MRT (TSE:6034), the current Marketable Securities is 円562 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRT (TSE:6034) Overvalued in 2026?

Based on GuruFocus' analysis, MRT stock appears to be overvalued. The current stock price of 円650.00 is trading 5.1% above its estimated GF Value™ of 円618.55. GuruFocus considers MRT to be Fairly Valued.

Key valuation signals for TSE:6034:

  • Marketable Securities: 円562 Mil
  • GF Value™: 円618.55 vs. price of 円650.00 (5.1% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MRT Business Description

Address 1-18-2 Jinnan, 3rd Floor, Frame Jinnanzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
60GF Score

Get the complete analysis for TSE:6034

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円650.00
Price
円618.55
GF Value